Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.080
-0.020 (-1.82%)
At close: Jul 1, 2025, 4:00 PM
1.100
+0.020 (1.85%)
After-hours: Jul 1, 2025, 6:11 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $66.90 million as of July 1, 2025. Its market cap has decreased by -70.49% in one year.
Market Cap
66.90M
Enterprise Value
-16.83M
1-Year Change
-70.49%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $66.90M, a decrease of -87.23%. That is a compound annual growth rate of -42.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2025 | 68.14M | -26.54% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |